Garcia D, Erkan D. Diagnosis and management of the antiphospholipid syndrome. Longo DL, editor. N Engl J Med. 2018;378:2010–21.

Article  CAS  PubMed  Google Scholar 

Andreoli L, Chighizola CB, Banzato A, Pons-Estel GJ, De Jesus GR, Erkan D, et al. Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature. Arthritis Care Res. 2013;65:1869–73.

Article  CAS  Google Scholar 

Asherson RA. The catastrophic antiphospholipid syndrome. J Rheumatol. 1992;19:508–12.

CAS  PubMed  Google Scholar 

• Barbhaiya M, Zuily S, Naden R, Hendry A, Manneville F, Amigo M-C, et al. ACR/EULAR antiphospholipid syndrome classification criteria. Ann Rheum Dis. 2023;2023:ard-2023-224609. This article presents the novel classification criteria for Antiphospholipid Syndrome (APS). The criteria encompass a thorough description of the data-driven and expert-based approach utilized, resulting in a comprehensive and stratified system that reflects current understanding of APS manifestations.

Google Scholar 

Dosekun AK, Pollak VE, Glas-Greenwalt P, Kant KS, Penovich P, Lebron-Berges A, et al. Ancrod in systemic lupus erythematosus with thrombosis. Clinical and fibrinolysis effects. Arch Intern Med. 1984;144:37–42.

Article  CAS  PubMed  Google Scholar 

Cervera R, Bucciarelli S, Plasín MA, Gómez-Puerta JA, Plaza J, Pons-Estel G, et al. Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of a series of 280 patients from the “CAPS Registry.” J Autoimmun. 2009;32:240–5.

Article  CAS  PubMed  Google Scholar 

Cervera R, Rodríguez-Pintó I, Espinosa G. The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: A comprehensive review. J Autoimmun. 2018;92:1–11.

Article  PubMed  Google Scholar 

Rodríguez-Pintó I, Moitinho M, Santacreu I, Shoenfeld Y, Erkan D, Espinosa G, et al. Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry. Autoimmun Rev. 2016;15:1120–4.

Article  PubMed  Google Scholar 

•• Cervera R, Rodríguez-Pintó I, Legault K, Erkan D. 16th international congress on antiphospholipid antibodies task force report on catastrophic antiphospholipid syndrome. Lupus. 2020;29:1594–600. This article summarizes the main aspects that were presented during the Task Force meeting at that Congress, offering up-to-date knowledge on pathogenesis, clinical and laboratory features, diagnosis and classification, precipitating factors, and treatment of CAPS.

Article  PubMed  Google Scholar 

Sevim E, Zisa D, Andrade D, Sciascia S, Pengo V, Tektonidou MG, et al. Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTION International Clinical Database and Repository. Arthritis Care Res. 2022;74:324–35.

Article  CAS  Google Scholar 

Nguyen Y, Yelnik CM, Morel N, Paule R, Stammler R, Plaçais L, et al. Determination of four homogeneous subgroups of patients with antiphospholipid syndrome: a cluster analysis based on 509 cases. Rheumatology. 2023;62:2813–9.

Article  CAS  PubMed  Google Scholar 

Asherson RA, Cervera R, de Groot PG, Erkan D, Boffa MC, Piette JC, et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus. 2003;12:530–4.

Article  CAS  PubMed  Google Scholar 

Erkan D, Espinosa G, Cervera R. Catastrophic antiphospholipid syndrome: updated diagnostic algorithms. Autoimmun Rev. 2010;10:74–9.

Article  PubMed  Google Scholar 

Pineton de Chambrun M, Larcher R, Pène F, Argaud L, Mayaux J, Jamme M, et al. In-hospital mortality-associated factors in patients with thrombotic antiphospholipid syndrome requiring ICU admission. Chest. 2020;157:1158–66.

Article  CAS  PubMed  Google Scholar 

• Pineton De Chambrun M, Larcher R, Pène F, Argaud L, Demoule A, Jamme M, et al. CAPS criteria fail to identify most severely-ill thrombotic antiphospholipid syndrome patients requiring intensive care unit admission. J Autoimmun. 2019;103:102292. (This article sheds light on APS patients hospitalized in the ICU, emphasizing the inadequacy of CAPS classification criteria, cautioning against their use for guiding CAPS-specific treatment.)

Article  PubMed  Google Scholar 

Stammler R, Nguyen Y, Yelnik C, Le Guern V, Lambert M, Paule R, et al. Precipitating factors of catastrophic antiphospholipid syndrome: the role of anticoagulant treatment in a series of 112 patients. J Thromb Haemost. 2023;21:1258–65.

Article  PubMed  Google Scholar 

Nochy D, Daugas E, Droz D, Beaufils H, Grünfeld J-P, Piette J-C, et al. The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol. 1999;10:507.

Article  CAS  PubMed  Google Scholar 

Alchi B, Griffiths M, Jayne D. What nephrologists need to know about antiphospholipid syndrome. Nephrol Dial Transplant. 2010;25:3147–54.

Article  PubMed  Google Scholar 

Hucker WJ, Chatzizisis YS, Steigner ML, Winters GL, Kirshenbaum JM. Myocardial catastrophe: a case of sudden, severe myocardial dysfunction. Circulation. 2014;130:854–62.

Article  PubMed  Google Scholar 

Cranley J, Krishnan U, Tweed K, Duehmke RM. Catastrophic antiphospholipid syndrome causing ST-segment elevation myocardial infarction with non-obstructive coronary arteries. BMJ Case Rep. 2019;12:bcr-2018-225495.

Article  Google Scholar 

Azoulay L-D, Pineton De Chambrun M, Larcher R, Pène F, Argaud L, Mayaux J, et al. Prevalence, characteristics and outcome of cardiac manifestations in critically-ill antiphospholipid syndrome patients. J Autoimmun. 2022;133:102908.

Article  CAS  PubMed  Google Scholar 

Dupré A, Morel N, Yelnik C, Moguelet P, Le Guern V, Stammler R, et al. Cutaneous involvement in catastrophic antiphospholipid syndrome in a multicenter cohort of 65 patients. JAMA Dermatol. 2023;159:62.

Article  PubMed  Google Scholar 

Espinosa G, Font J, García-Pagan JC, Tàssies D, Reverter JC, Gaig C, et al. Budd-Chiari syndrome secondary to antiphospholipid syndrome: clinical and immunologic characteristics of 43 patients. Medicine (Baltimore). 2001;80:345–54.

Article  CAS  PubMed  Google Scholar 

Uthman I, Khamashta M. The abdominal manifestations of the antiphospholipid syndrome. Rheumatology (Oxford). 2007;46:1641–7.

Article  CAS  PubMed  Google Scholar 

Cervera R, Piette J-C, Font J, Khamashta MA, Shoenfeld Y, Camps MT, et al. Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients: Clinical and Immunologic Manifestations of APS. Arthritis Rheum. 2002;46:1019–27.

Article  PubMed  Google Scholar 

Podolak B, Blickstein D, Inbal A, Eizner S, Rahamimov R, Yussim A, Mor E. Renal transplantation in a patient with catastrophic antiphospholipid syndrome and heparin-induced thrombocytopenia. Isr Med Assoc J. 2014;16(1):61–2.

Hsieh J, Kuzmanovic I, Vargas MI, Momjian-Mayor I. Cerebral venous thrombosis due to cryptogenic organising pneumopathy with antiphospholipid syndrome worsened by heparin-induced thrombocytopenia. Case Reports. 2013;2013:bcr2013009500.

Google Scholar 

Gelisse E, Gratia E, Just B, Mateu P. Catastrophic antiphospholipid syndrome and heparin-induced thrombocytopenia presenting with adrenal insufficiency caused by bilateral hemorrhagic adrenal infarction during sepsis. Annales Françaises d’Anesthésie et de Réanimation. 2014;33:e83–4.

Article  CAS  PubMed  Google Scholar 

Tun NT, Krishnamurthy M, Snyder R. Catastrophic antiphospholipid syndrome and heparin-induced thrombocytopenia-related diseases or chance association? Blood Coag Fibrinol. 2015;26:214–9.

Article  Google Scholar 

Adediran S, Agostino N. Coexistence of antiphospholipid syndrome and heparin-induced thrombocytopenia in a patient with recurrent venous thromboembolism. Case Reports in Hematol. 2017;2017:1–4.

Article  Google Scholar 

Klinkhammer B, Gruchalla M. Is there an association between heparin-induced thrombocytopenia (HIT) and autoimmune disease? WMJ. 2018;117(1):13–7.

Martin-Toutain I, Piette J, Diemert M, Faucher C, Jobic L, Ankri A. Hgh prevalence of antibodies to platelet factor 4 heparin in patients with antiphospholipid antibodies in absence of heparin-induced thrombocytopenia. Lupus. 2007;16:79–83.

Article  CAS  PubMed  Google Scholar 

Pauzner R, Greinacher A, Selleng K, Althaus K, Shenkman B, Seligsohn U. False-positive tests for heparin-induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus. J Thromb Haemost. 2009;7:1070–4.

Article  CAS  PubMed  Google Scholar 

Perunicic J, Antonijevic NM, Miljic P, Djordjevic V, Mikovic D, Kovac M, et al. Clinical challenge: heparin-induced thrombocytopenia type II (HIT II) or pseudo-HIT in a patient with antiphospholipid syndrome. J Thromb Thrombolysis. 2008;26:142–6.

Article  PubMed  Google Scholar 

Alpert DR, Salmon JE. False-positive tests for heparin-induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus: a rebuttal. J Thromb Haemost. 2010;8:1439–41.

Article  CAS  PubMed  Google Scholar 

Bucciarelli S, Espinosa G, Cervera R, Erkan D, Gómez-Puerta JA, Ramos-Casals M, et al. Mortality in the catastrophic antiphospholipid syndrome: Causes of death and prognostic factors in a series of 250 patients. Arthritis Rheum. 2006;54:2568–76.

Article  PubMed  Google Scholar 

Devreese KMJ, Groot PG, Laat B, Erkan D, Favaloro EJ, Mackie I, et al. Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: Update of the guidelines for lupus anticoagulant detection and interpretation. J Thromb Haemost. 2020;18:2828–39.

Article  CAS  PubMed  Google Scholar 

• Rodríguez-Pintó I, Espinosa G, Erkan D, Shoenfeld Y, Cervera R, CAPS Registry Project Group, et al. The effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients. Rheumatology. 2018;57:1264–70. In this retrospective study from the CAPS registry, triple therapy was associated with a reduced mortality risk of approximately 46% in CAPS patients.

Article  PubMed  Google Scholar 

Ortel TL, Erkan D, Kitchens CS. How I treat catastrophic thrombotic syndromes. Blood. 2015;126:1285–93.

Article  CAS  PubMed  Google Scholar 

Legault K, Schunemann H, Hillis C, Yeung C, Akl EA, Carrier M, et al. McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome. J Thromb Haemost. 2018;16:1656–64.

Article